Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.25EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.25EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.37ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.37ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.37EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.37EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XAY.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XAY.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAY.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.1.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CH.1.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used